Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...

When faced with the myriad diseases and equally numerous targets for potential drugs the company could pursue, Kewalramani ...

At BIO 2025, pharmaphorum Editor in Chief spoke with Hanadie Yousef, CEO of Juvena Therapeutics, a biotech focused on discovering and developing tissue-restorative biologics for chronic age-related ...

How TIME and Statista Determined the World's Most Sustainable Companies of 2025 In the fight against climate change, companies are navigating ...

With the current market volatility, knowing which biotech stocks to buy on the dip can lead to lucrative returns as the industry is likely to recover faster than the market average. After all ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

The company plans to submit efsitora, its once-weekly insulin for type 2 diabetes, to global regulators by end-2026 following ...

Scientists have engineered bacteria to turn plastic waste into paracetamol, offering a sustainable new path for medicine and ...

William Rutter and biochemistry professor Pablo D. T. Valenzuela, Ph.D., create the biotech firm Chiron Corporation. The company becomes the first to map the DNA structure of HIV and produce the world ...

It said "Big Pharma is diversifying geographically, benefiting Indian CRDMOs with small molecule expertise". The report highlighted some major pharma companies (Including Piramal Pharma, Syngene, ...

Shares of Sana Biotechnology jumped after the company reported positive results for the latest study transplanting its UP421 cell therapy into a patient with type 1 diabetes. The stock was up 21% at ...